Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma
Clinical trial NCT01754376 · TERMINATED
Trial details
- NCT number
- NCT01754376
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.